Which medication is FDA-approved for the treatment of Bulimia?

Fluoxetine is the FDA-approved medication specifically indicated for the treatment of Bulimia Nervosa. Clinical studies have demonstrated its efficacy in reducing binge-eating and purging behaviors associated with this eating disorder. As a selective serotonin reuptake inhibitor (SSRI), fluoxetine works by increasing serotonin levels in the brain, which can help improve mood and reduce anxiety, factors that are often intertwined with bulimia.

The use of fluoxetine for this specific condition is supported by the evidence of its impact on reducing the frequency of binge-eating episodes and promoting recovery from the disorder. This makes it a crucial component in the management of Bulimia Nervosa, alongside psychotherapy and other supportive measures.

Other medications mentioned, while they may have benefits for different conditions or symptoms, are not specifically FDA-approved for treating Bulimia. For instance, Lisdexamfetamine is more commonly used for ADHD and has not been established as effective for bulimia. Sertraline, another SSRI, is effective for various anxiety and mood disorders, but fluoxetine holds the specific approval for bulimia. Topiramate, often used off-label for its anticonvulsant properties and as a weight-loss aid, lacks sufficient evidence to support its use in the treatment of Bulimia Nerv